<DOC>
	<DOCNO>NCT00538603</DOCNO>
	<brief_summary>Multi-national , randomize , phase III , GCIG Intergroup study compare pegylated liposomal Doxorubicin ( CAELYX ) Carboplatin vs. Paclitaxel Carboplatin patient epithelial ovarian cancer late relapse . ( CALYPSO )</brief_summary>
	<brief_title>Multi-national , Randomized , Phase III , GCIG Intergroup Study Comparing Pegylated Liposomal Doxorubicin ( CAELYX ) Carboplatin vs. Paclitaxel Carboplatin Patients With Epithelial Ovarian Cancer Late Relapse . ( CALYPSO )</brief_title>
	<detailed_description />
	<mesh_term>Ovarian Neoplasms</mesh_term>
	<mesh_term>Neoplasms , Glandular Epithelial</mesh_term>
	<mesh_term>Paclitaxel</mesh_term>
	<mesh_term>Liposomal doxorubicin</mesh_term>
	<mesh_term>Albumin-Bound Paclitaxel</mesh_term>
	<mesh_term>Carboplatin</mesh_term>
	<mesh_term>Doxorubicin</mesh_term>
	<criteria>Patients epithelial Ovarian cancer late relapse</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>December 2015</verification_date>
</DOC>